Literature DB >> 911795

Rearrangement of chorismate to prephenate. Use of chorismate mutase inhibitors to define the transition state structure.

P R Andrews, E N Cain, E Rizzardo, G D Smith.   

Abstract

The enzymically catalyzed conversion of chorismate to prephenate may proceed through either a chair-like or a boat-like transition state. To distinguish between these alternatives, we have prepared a series of structural analogues of the two possible transition state structures and tested them as inhibitors of chorismate mutase-prephenate dehydrogenase from Escherichia coli K12. The results indicate that the enzymically catalyzed reaction passes through a chair-like intermediate. None of the compounds studied is an ideal transition state analogue; it seems likely that the partial bond structure of the transition state precludes the corresponding orientation of the side chain in stable molecules. Nevertheless, the new inhibitors are stronger than any previously available, and the degree of inhibition is consistent with bacteriostatic activity recently observed in some of the compounds.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 911795     DOI: 10.1021/bi00641a015

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  Exploring the active site of chorismate mutase by combinatorial mutagenesis and selection: the importance of electrostatic catalysis.

Authors:  P Kast; M Asif-Ullah; N Jiang; D Hilvert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

2.  Expanding the results of a high throughput screen against an isochorismate-pyruvate lyase to enzymes of a similar scaffold or mechanism.

Authors:  Kathleen M Meneely; Qianyi Luo; Andrew P Riley; Byron Taylor; Anuradha Roy; Ross L Stein; Thomas E Prisinzano; Audrey L Lamb
Journal:  Bioorg Med Chem       Date:  2014-09-16       Impact factor: 3.641

3.  Biochemical and structural characterization of the secreted chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv: an *AroQ enzyme not regulated by the aromatic amino acids.

Authors:  Sook-Kyung Kim; Sathyavelu K Reddy; Bryant C Nelson; Gregory B Vasquez; Andrew Davis; Andrew J Howard; Sean Patterson; Gary L Gilliland; Jane E Ladner; Prasad T Reddy
Journal:  J Bacteriol       Date:  2006-12       Impact factor: 3.490

4.  Binding of a high-energy substrate conformer in antibody catalysis.

Authors:  A P Campbell; T M Tarasow; W Massefski; P E Wright; D Hilvert
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.